$ASNS
ACTELIS NETWORKS INC Stock $asns

$asns Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023024106 Filed on March 29, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$1.848M	$2.534M	$8.831M
YoY Change	-1.18%		3.29%
Cost Of Revenue	$1.160M	$1.463M	$4.721M
YoY Change	-10.08%		3.08%
Gross Profit	$688.0K	$1.071M	$4.110M
YoY Change	18.21%		3.53%
Gross Profit Margin	37.23%	42.27%	46.54%
Selling, General & Admin	$1.794M	$2.358M	$7.445M
YoY Change	31.91%		119.62%
% of Gross Profit	260.76%	220.17%	181.14%
Research & Development	$757.0K	$717.0K	$2.766M
YoY Change	16.46%		13.36%
% of Gross Profit	110.03%	66.95%	67.3%
Depreciation & Amortization	$7.000K	-$6.000K	$23.00K
YoY Change	-450.0%		-42.5%
% of Gross Profit	1.02%	-0.56%	0.56%
Operating Expenses	$2.551M	$3.075M	$10.21M
YoY Change	20.5%		75.15%
Operating Profit	-$1.863M	-$2.004M	-$6.101M
YoY Change	21.37%		228.01%
Interest Expense	$180.0K	-$478.0K	$830.0K
YoY Change	68.22%		-135.93%
% of Operating Profit
Other Income/Expense, Net	$148.0K		-$4.051M
YoY Change	-104.61%		275.09%
Pretax Income	-$1.895M	-$2.482M	-$10.98M
YoY Change	-59.16%		109.18%
Income Tax
% Of Pretax Income
Net Earnings	-$1.895M	-$2.482M	-$10.98M
YoY Change	-59.15%		109.18%
Net Earnings / Revenue	-102.54%	-97.95%	-124.36%
Basic Earnings Per Share	-$1.09		-$0.95
Diluted Earnings Per Share	-$1.09	-$0.14	-$0.95
COMMON SHARES
Basic Shares Outstanding	17.41M shares	17.32M shares	11.62M shares
Diluted Shares Outstanding	1.734M shares		11.62M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.618M	$5.565M	$5.565M
YoY Change	167.0%		706.52%
Cash & Equivalents	$808.0K	$3.943M	$3.943M
Short-Term Investments	$810.0K	$1.622M	$1.622M
Other Short-Term Assets	$1.193M	$1.129M	$1.054M
YoY Change	14.16%		276.43%
Inventory	$1.274M	$1.179M	$1.179M
Prepaid Expenses		$473.0K
Receivables	$2.473M	$3.034M	$3.109M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.558M	$10.91M	$10.91M
YoY Change	67.3%	163.77%	163.45%
LONG-TERM ASSETS
Property, Plant & Equipment	$76.00K	$80.00K	$80.00K
YoY Change	-92.21%	-22.33%	-20.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.367M	$3.832M	$3.832M
YoY Change	1130.96%		751.56%
Total Long-Term Assets	$5.443M	$3.912M	$3.912M
YoY Change	286.03%	612.57%	624.44%
TOTAL ASSETS
Total Short-Term Assets	$6.558M	$10.91M	$10.91M
Total Long-Term Assets	$5.443M	$3.912M	$3.912M
Total Assets	$12.00M	$14.82M	$14.82M
YoY Change	125.16%	216.37%	216.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.400M	$1.781M	$1.781M
YoY Change	-9.09%		-7.24%
Accrued Expenses	$2.389M	$1.190M	$2.138M
YoY Change	-7.76%	46.37%	24.3%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.206M	$553.0K	$553.0K
YoY Change	-83.41%	-27.04%	-27.24%
Total Short-Term Liabilities	$6.372M	$6.202M	$6.202M
YoY Change	-47.73%	4.22%	4.24%
LONG-TERM LIABILITIES
Long-Term Debt	$3.712M	$4.625M	$4.625M
YoY Change	-54.06%		-55.44%
Other Long-Term Liabilities	$33.00K	$727.0K	$727.0K
YoY Change	-100.4%	820.25%	-69.32%
Total Long-Term Liabilities	$4.214M	$5.352M	$5.352M
YoY Change	-4782.22%	-58.0%	-58.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.372M	$6.202M	$6.202M
Total Long-Term Liabilities	$4.214M	$5.352M	$5.352M
Total Liabilities	$10.59M	$11.55M	$11.55M
YoY Change	-55.82%	-38.2%	-38.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$35.30M	-$33.40M
YoY Change		48.98%
Common Stock	$1.000K	$1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.415M	$3.265M	$3.265M
YoY Change
Total Liabilities & Shareholders Equity	$12.00M	$14.82M	$14.82M
YoY Change	125.16%	216.37%	216.65%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$1.895M	-$2.482M	-$10.98M
YoY Change	-59.15%		109.18%
Depreciation, Depletion And Amortization	$7.000K	-$6.000K	$23.00K
YoY Change	-450.0%		-42.5%
Cash From Operating Activities	-$1.705M	-$1.992M	-$7.768M
YoY Change	238.29%		184.54%
INVESTING ACTIVITIES
Capital Expenditures	$3.000K	-$34.00K
YoY Change	-123.08%
Acquisitions
YoY Change
Other Investing Activities	-$331.0K	-$3.966M	-$4.034M
YoY Change	26.34%
Cash From Investing Activities	-$334.0K	-$3.932M	-$4.034M
YoY Change	21.45%		7968.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$192.0K		$1.241M
YoY Change	48.84%
Cash From Financing Activities	-$242.0K	-742.0K	$15.29M
YoY Change	-11.03%		427.1%
NET CHANGE
Cash From Operating Activities	-$1.705M	-1.992M	-$7.768M
Cash From Investing Activities	-$334.0K	-3.932M	-$4.034M
Cash From Financing Activities	-$242.0K	-742.0K	$15.29M
Net Change In Cash	-$2.281M	-6.666M	$3.484M
YoY Change	117.03%		2803.33%
FREE CASH FLOW
Cash From Operating Activities	-$1.705M	-$1.992M	-$7.768M
Capital Expenditures	$3.000K	-$34.00K
Free Cash Flow	-$1.708M	-$1.958M	-$7.768M
YoY Change	247.86%		189.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	asns	Common Stock Value1 CommonStockValue1		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41375
CY2022	dei	Entity Registrant Name EntityRegistrantName	Actelis Networks, Inc
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-2160309
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	4039 Clipper Court
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Fremont
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94538
CY2022	dei	City Area Code CityAreaCode	(510)
CY2022	dei	Local Phone Number LocalPhoneNumber	545-1045
CY2022	dei	Security12b Title Security12bTitle	Common stock, par value $0.0001 per share
CY2022	dei	Trading Symbol TradingSymbol	ASNS
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	7034875	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17407565	shares
CY2022	dei	Auditor Name AuditorName	Kesselman & Kesselman
CY2022	dei	Auditor Firm AuditorFirmId	1309
CY2022	dei	Auditor Location AuditorLocation	Tel Aviv, Israel
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3943000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	693000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	1622000	usd
CY2022Q4	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	451000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	125000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	61000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	3034000	usd
CY2021Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	2147000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1179000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	897000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	678000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	398000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	10907000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	4135000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	80000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103000	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	492000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	336000	usd
CY2022Q4	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	2027000	usd
CY2021Q4	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	102000	usd
CY2022Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	239000	usd
CY2021Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	266000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	726000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	12000	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	78000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3912000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	549000	usd
CY2022Q4	us-gaap	Assets Assets	14819000	usd
CY2021Q4	us-gaap	Assets Assets	4684000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	553000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	758000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	8000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	177000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1781000	usd
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1920000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	484000	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	673000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	793000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	703000	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	900000	usd
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	818000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	445000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1238000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	902000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6202000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5951000	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	4625000	usd
CY2021Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	5473000	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	164000	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1972000	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	4905000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	237000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	278000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	315000	usd
CY2022Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	48000	usd
CY2021Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	79000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5352000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12744000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	11554000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	18695000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7988691	shares
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	5585000	usd
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	5585000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	11009315	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17379861	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17379861	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2050404	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2050404	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	2803774	shares
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	2803774	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1783773	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1783773	shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	36666000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2824000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33402000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22420000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3265000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-19596000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14819000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4684000	usd
CY2022	us-gaap	Revenues Revenues	8831000	usd
CY2021	us-gaap	Revenues Revenues	8545000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	4721000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	4575000	usd
CY2022	us-gaap	Gross Profit GrossProfit	4110000	usd
CY2021	us-gaap	Gross Profit GrossProfit	3970000	usd
CY2022	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	2766000	usd
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	2443000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3282000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2204000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4163000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1183000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	10211000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	5830000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-6101000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1860000	usd
CY2022	us-gaap	Interest Expense InterestExpense	830000	usd
CY2021	us-gaap	Interest Expense InterestExpense	690000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4051000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2701000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10982000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-5251000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.95
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.56
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11621238	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2048788	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-14398000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	53000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-5251000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-19596000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	220000	usd
CY2022	asns	Stock Issued During Period Value Conversion Of Convertible Preferred Stock To Common Stock Upon Initial Public Offering StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering	5585000	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	14675000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	6553000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3600000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3190000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	15000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10982000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3265000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10982000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-5251000	usd
CY2022	us-gaap	Depreciation Depreciation	23000	usd
CY2021	us-gaap	Depreciation Depreciation	37000	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	1049000	usd
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	1031000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	147000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	102000	usd
CY2022	asns	Exchange Rate Differences ExchangeRateDifferences	-642000	usd
CY2021	asns	Exchange Rate Differences ExchangeRateDifferences	167000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	220000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	53000	usd
CY2022	asns	Changes In Fair Value Related To Convertible Loan ChangesInFairValueRelatedToConvertibleLoan	1648000	usd
CY2021	asns	Changes In Fair Value Related To Convertible Loan ChangesInFairValueRelatedToConvertibleLoan	1342000	usd
CY2022	asns	Changes In Fair Value Related To Convertible Note ChangesInFairValueRelatedToConvertibleNote	1753000	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	15000	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	830000	usd
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	235000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	887000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	731000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	44000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	429000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-78000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	280000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	236000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	492000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-27000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-139000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-217000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-25000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	92000	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	508000	usd
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	516000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-41000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	29000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7768000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2726000	usd
CY2022	asns	Proceeds From Short Term Debts ProceedsFromShortTermDebts	-1622000	usd
CY2022	asns	Proceeds From Issuance Long Term Debts ProceedsFromIssuanceLongTermDebts	66000	usd
CY2022	asns	Restricted Long Term Bank Deposit RestrictedLongTermBankDeposit	-27000	usd
CY2022	asns	Restricted Bank Deposit RestrictedBankDeposit	-2451000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	54000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4034000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-54000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2904000	usd
CY2022	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	18697000	usd
CY2022	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	2175000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1241000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15286000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2904000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-72000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	167000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3484000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	124000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	795000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	671000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4279000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	795000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3943000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	693000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	336000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	102000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4279000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	795000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	818000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	511000	usd
CY2021	asns	Additional Warrants AdditionalWarrants	95000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	237000	usd
CY2022	asns	Conversion Of Convertible Loan To Common Stock Upon Initial Public Offering ConversionOfConvertibleLoanToCommonStockUponInitialPublicOffering	6553000	usd
CY2022	asns	Conversion Of Convertible Note To Common Stock Upon Initial Public Offering ConversionOfConvertibleNoteToCommonStockUponInitialPublicOffering	3600000	usd
CY2022	asns	Conversion Of Warrants To Common Stock Upon Initial Public Offering ConversionOfWarrantsToCommonStockUponInitialPublicOffering	3190000	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	5585000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	15000	usd
CY2021Q4	us-gaap	Lines Of Credit Fair Value Disclosure LinesOfCreditFairValueDisclosure	2000000	usd
CY2022	asns	Incurred Losses IncurredLosses	10982000	usd
CY2021	asns	Incurred Losses IncurredLosses	5251000	usd
CY2022	asns	Negative Cash Flows From Operations NegativeCashFlowsFromOperations	7768000	usd
CY2021	asns	Negative Cash Flows From Operations NegativeCashFlowsFromOperations	2726000	usd
CY2022Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	33402000	usd
CY2022	us-gaap	Dividends Cash DividendsCash	6016000	usd
CY2022Q4	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	2375	usd
CY2022Q2	us-gaap	Shares Issued SharesIssued	4212500	shares
CY2022Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	462500	shares
CY2022Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	4
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	15400000	usd
CY2022	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	1000000	usd
CY2022Q4	asns	Warrants Exercisable Price WarrantsExercisablePrice	294875	shares
CY2022	us-gaap	Fiscal Period Duration FiscalPeriodDuration	P5Y
CY2022	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	5
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	145000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.54	pure
CY2022Q4	asns	Riskfree Rate RiskfreeRate	0.0301	pure
CY2022	us-gaap	Deferred Compensation Arrangement With Individual Maximum Contractual Term1 DeferredCompensationArrangementWithIndividualMaximumContractualTerm1	P5Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.95
CY2022Q4	asns	Non Voting Common Stock NonVotingCommonStock	1783773	shares
CY2022Q4	us-gaap	Property Plant And Equipment Salvage Value Percentage PropertyPlantAndEquipmentSalvageValuePercentage	0.07	pure
CY2022	asns	Computers Electronic Equipment And Software Percenatage ComputersElectronicEquipmentAndSoftwarePercenatage	Mainly 33%
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><b>b.</b></td><td><b>Use of estimates in preparation of financial statements </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, Fair value of financial instruments, inventory write-offs, as well as in estimates used in applying the revenue recognition policy (See note 2l). The Company’s management believes that the estimates, judgment, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p>
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	125000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	61000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	64000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2022	asns	Schedule Of Annual Rates Of Depreciation ScheduleOfAnnualRatesOfDepreciation	<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; width: 75%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers, electronic equipment and software</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mainly 33%</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office furniture and equipment</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements </span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By the shorter of lease term and the estimated useful life of the asset</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b> </b></p>
CY2022	asns	Leasehold Improvements Percentage LeaseholdImprovementsPercentage	By the shorter of lease term and the estimated useful life of the asset
CY2022	us-gaap	Revenue Recognition Allowances RevenueRecognitionAllowances	<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><b>l.</b></td><td><b>Revenue recognition</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">The Company’s product consists of hardware and an embedded software that function together to deliver the product’s essential functionality. The embedded software is essential to the functionality of the Company’s products. The Company’s products are sold with a two-year warranty for repairs or replacements of the product in the event of damage or failure during the term of the support period, which is accounted for as a standard warranty. Services relating to repair or replacement of hardware beyond the standard warranty period are offered under renewable, fee-based contracts and include telephone support, remote diagnostics and access to on-site technical support personnel.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">The Company also offers its customers other management software. The Company sells its other non-embedded software either as perpetual or as term-based licenses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">The Company provides, to certain customers, software updates that it chooses to develop, which the Company refers to as unspecified software updates, and enhancements related to the Company’s management software through support service contracts. The Company also offers its customers product support services which include telephone support, remote diagnostics and access to on-site technical support personnel.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">The Company’s customers are comprised of resellers, system integrators and distributors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">The Company follows five steps to record revenue: (i) identify the contract with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) it satisfies its performance obligations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the good or service either on its own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the goods or services is separately identifiable from other promises in the contract.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring goods or services to the customer. The Company’s contracts do not include additional discounts once product price is set, right of returns, significant financing components or any forms of variable consideration.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">The Company uses the practical expedient and does not assess the existence of a significant financing component when the difference between payment and revenue recognition is less than a year. The Company’s service period is for one year and is paid for either up front or on a quarterly basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt .75in; text-align: justify; text-indent: 0in"><span style="text-decoration:underline">Sales of products</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">Most of the Company’s contracts are of a single performance obligation (sales of the product with a standard warranty) thus the entire transaction price is allocated to the single performance obligation. In addition, the Company also sells separate services such as product support service and extended warranty.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt .75in; text-align: justify; text-indent: 0in"><span style="text-decoration:underline">Sales of software with related services</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">The Company sells perpetual management software and term-based licenses for its management software together with related services. The perpetual management software stand-alone selling price is established by taking in consideration available information such as historical selling prices of the perpetual license, geographic location, and market conditions. For contracts that contain more than one identified performance obligation (a term-based license for its management software together with related services), the stand-alone selling price of a term-based license, is based on a ratio from the relevant perpetual management software stand-alone selling price. The stand-alone selling price of the related service is then determined by applying the residual method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">Revenue from selling the Company’s product and/or the software management (either as term-based or perpetual) is recognized at a point in time which is typically at the time of shipment of products to the customer or when the code is transferred, respectively. Revenue from services (e.g., product support service, software support service or extended warranty) is recognized on a straight-line basis over the service period, as a time-based measure of progress best reflects our performance in satisfying this performance obligation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"> </p>
CY2021	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	516000	usd
CY2022Q4	asns	Right Of Use Asset RightOfUseAsset	1046000	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1450000	usd
CY2022	us-gaap	Product Warranty Expense ProductWarrantyExpense	8000	usd
CY2021Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	102000	usd
CY2021Q4	us-gaap	Other Notes Payable OtherNotesPayable	4905000	usd
CY2021	us-gaap	Product Warranty Expense ProductWarrantyExpense	2149000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><b>r.</b></td><td><b>Concentrations of credit risk</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7in"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, and trade receivables. Cash and cash equivalents and restricted cash are placed with banks and financial institutions in the United States and Israel.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">Management believes that the financial institutions that hold the Company’s investments are financially sound and, accordingly, present minimal credit risk with respect to those investments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">The Company’s trade receivables are derived primarily from telecommunication operators, the Company’s reseller customers and enterprises located mainly in the United States, Europe, and Asia.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">Credit risk with respect to trade receivables exists to the full extent of the amounts presented in the consolidated financial statements. Management makes judgments as to its ability to collect outstanding accounts receivable and provides allowances for the applicable portion of accounts receivable when collection becomes doubtful.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in">Management provides allowances based upon a specific review of all significant outstanding invoices, analysis of its historical collection experience, and current economic trends. If the historical data used to calculate the allowance for doubtful accounts does not reflect the Company’s future ability to collect outstanding accounts receivable, additional provisions for doubtful accounts may be needed, and the future results of operations could be materially affected.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify">The Company has major customers, representing:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29% and 46% of the Company Trade receivables balance as of December 31, 2022 and December 31, 2021 respectively.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23% and 0% of the Company Trade receivables balance as of December 31, 2022 and December 31, 2021 respectively.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 1in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-111">3.</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10% and 4% of the Company Trade receivables balance as of December 31, 2022 and December 31, 2021 respectively.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0.75in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.75in">See note 18 for details regarding the revenues from these customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .75in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">The Company does not see any credit risk regarding this balance, as most of the remaining balance was paid off after the balance sheet date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"> </p>
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P2Y
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	96000	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	158000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	158000	usd
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	90000	usd
CY2022	asns	Cost Incurred CostIncurred	-7000	usd
CY2021	asns	Cost Incurred CostIncurred	-68000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-55000	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	136000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	96000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	158000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.03	pure
CY2022	us-gaap	Royalty Expense RoyaltyExpense	257000	usd
CY2021	us-gaap	Royalty Expense RoyaltyExpense	258000	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.50	pure
CY2022	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	182000	usd
CY2021	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	156000	usd
CY2022	asns	Gainloss On Amounts Funded In Respect Of Employee Rights Upon Retirement Totaled GainlossOnAmountsFundedInRespectOfEmployeeRightsUponRetirementTotaled	-4000	usd
CY2021	asns	Gainloss On Amounts Funded In Respect Of Employee Rights Upon Retirement Totaled GainlossOnAmountsFundedInRespectOfEmployeeRightsUponRetirementTotaled	-8000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	9000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	6000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2022	asns	Restricted Stock Units Term RestrictedStockUnitsTerm	P3Y
CY2022	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.40	pure
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	593000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	356000	usd
CY2022	us-gaap	Workers Compensation Discount Percent WorkersCompensationDiscountPercent	0.65	pure
CY2022Q4	asns	Operating Lease Rightof Use Assets OperatingLeaseRightofUseAssets	1046000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	586000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	541000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	1179000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	897000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	147000	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	102000	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	473000	usd
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	194000	usd
CY2022Q4	us-gaap	Receivables From Brokers Dealers And Clearing Organizations ReceivablesFromBrokersDealersAndClearingOrganizations	130000	usd
CY2021Q4	us-gaap	Receivables From Brokers Dealers And Clearing Organizations ReceivablesFromBrokersDealersAndClearingOrganizations	82000	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	75000	usd
CY2021Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	122000	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	678000	usd
CY2021	us-gaap	Interest Expense Other InterestExpenseOther	398000	usd
CY2022	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	9739000	usd
CY2021	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	9739000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9659000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9636000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	80000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103000	usd
CY2022	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	23000	usd
CY2021	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	37000	usd
CY2022	us-gaap	Leveraged Leases Income Statement Investment Tax Credit Recognized On Leveraged Leases LeveragedLeasesIncomeStatementInvestmentTaxCreditRecognizedOnLeveragedLeases	168000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	10000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	726000	usd
CY2022Q4	asns	Current Operating Lease Liabilities CurrentOperatingLeaseLiabilities	445000	usd
CY2022Q4	asns	Non Current Operating Lease Liabilities NonCurrentOperatingLeaseLiabilities	237000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	682000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	747000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0349	pure
CY2022	asns	Fixed Payments FixedPayments	723000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	24000	usd
CY2022	us-gaap	Lease Cost LeaseCost	747000	usd
CY2022Q4	asns	Lessee Operating Lease Liability Payments Due Four Year LesseeOperatingLeaseLiabilityPaymentsDueFourYear	704000	ils
CY2022Q4	asns	Lessee Operating Lease Liability Payments Due Five Year LesseeOperatingLeaseLiabilityPaymentsDueFiveYear	9000	usd
CY2021Q1	asns	Lessee Operating Lease Liability Payments Due Five Year LesseeOperatingLeaseLiabilityPaymentsDueFiveYear	3684000	ils
CY2021Q1	asns	Lessee Operating Lease Liability Payments Due Five Year LesseeOperatingLeaseLiabilityPaymentsDueFiveYear	-1047000	usd
CY2022Q4	asns	Lessee Operating Lease Liability Payments Due Five Year LesseeOperatingLeaseLiabilityPaymentsDueFiveYear	704000	ils
CY2022Q4	asns	Lessee Operating Lease Liability Payments After Year Five LesseeOperatingLeaseLiabilityPaymentsAfterYearFive	129000	usd
CY2021Q1	asns	Lessee Operating Lease Liability Payments After Year Five LesseeOperatingLeaseLiabilityPaymentsAfterYearFive	303000	ils
CY2021Q1	asns	Lessee Operating Lease Liability Payments After Year Five LesseeOperatingLeaseLiabilityPaymentsAfterYearFive	-86000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1190000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	813000	usd
CY2022	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	48000	usd
CY2021	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	79000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1238000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	902000	usd
CY2020Q3	us-gaap	Amount Of Regulatory Assistance Received1 AmountOfRegulatoryAssistanceReceived1	150000	usd
CY2020Q3	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.0375	pure
CY2021Q1	us-gaap	Amount Of Regulatory Assistance Received1 AmountOfRegulatoryAssistanceReceived1	191000	usd
CY2021Q1	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.01	pure
CY2021Q1	asns	Principal And Interestterm principalAndInterestterm	P2Y
CY2020Q4	asns	New Loan NewLoan	20000000	ils
CY2020Q4	asns	New Loan NewLoan	600000	usd
CY2020Q4	us-gaap	Financing Receivable Loan In Process FinancingReceivableLoanInProcess	3000000	usd
CY2021Q1	asns	Additional Loan Value AdditionalLoanValue	2000000	usd
CY2022Q4	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.096	pure
CY2022	asns	Adjustment Of Warrants Granted For Service AdjustmentOfWarrantsGrantedForService	1500000	usd
CY2021Q4	us-gaap	Investment Company Increase From Payment By Affiliate And Gain Loss From Investment In Violation InvestmentCompanyIncreaseFromPaymentByAffiliateAndGainLossFromInvestmentInViolation	1000000	usd
CY2021Q4	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.096	pure
CY2022	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	1800000	usd
CY2022Q4	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Outstanding Balance CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesOutstandingBalance	5016000	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	544000	usd
CY2022Q4	asns	Loan Agreement Value loanAgreementValue	2000000	usd
CY2022Q4	asns	Lessee Operating Lease Liability Payments Due Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueTwelveMonths	9000	usd
CY2021Q1	asns	Lessee Operating Lease Liability Payments Due Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueTwelveMonths	3684000	ils
CY2021Q1	asns	Lessee Operating Lease Liability Payments Due Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueTwelveMonths	-1047000	usd
CY2022Q4	asns	Lessee Operating Lease Liability Payments Due Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueTwelveMonths	704000	ils
CY2022Q4	asns	Lessee Operating Lease Liability Payments Due Two Year LesseeOperatingLeaseLiabilityPaymentsDueTwoYear	9000	usd
CY2021Q1	asns	Lessee Operating Lease Liability Payments Due Two Year LesseeOperatingLeaseLiabilityPaymentsDueTwoYear	5567000	ils
CY2021Q1	asns	Lessee Operating Lease Liability Payments Due Two Year LesseeOperatingLeaseLiabilityPaymentsDueTwoYear	-1582000	usd
CY2022Q4	asns	Lessee Operating Lease Liability Payments Due Two Year LesseeOperatingLeaseLiabilityPaymentsDueTwoYear	1080000	ils
CY2022Q4	asns	Lessee Operating Lease Liability Payments Due Three Year LesseeOperatingLeaseLiabilityPaymentsDueThreeYear	9000	usd
CY2021Q1	asns	Lessee Operating Lease Liability Payments Due Three Year LesseeOperatingLeaseLiabilityPaymentsDueThreeYear	3684000	ils
CY2021Q1	asns	Lessee Operating Lease Liability Payments Due Three Year LesseeOperatingLeaseLiabilityPaymentsDueThreeYear	-1047000	usd
CY2022Q4	asns	Lessee Operating Lease Liability Payments Due Three Year LesseeOperatingLeaseLiabilityPaymentsDueThreeYear	704000	ils
CY2022Q4	asns	Lessee Operating Lease Liability Payments Due Four Year LesseeOperatingLeaseLiabilityPaymentsDueFourYear	9000	usd
CY2021Q1	asns	Lessee Operating Lease Liability Payments Due Four Year LesseeOperatingLeaseLiabilityPaymentsDueFourYear	3684000	ils
CY2021Q1	asns	Lessee Operating Lease Liability Payments Due Four Year LesseeOperatingLeaseLiabilityPaymentsDueFourYear	-1047000	usd
CY2022Q4	asns	Lessee Operating Lease Liability Payments After Year Five LesseeOperatingLeaseLiabilityPaymentsAfterYearFive	60000	ils
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12000	usd
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5673000	ils
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1612000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1239000	ils
CY2022Q4	asns	Total Loans Payments TotalLoansPayments	162000	usd
CY2021Q1	asns	Total Loans Payments TotalLoansPayments	14935000	ils
CY2021Q1	asns	Total Loans Payments TotalLoansPayments	-4244000	usd
CY2022Q4	asns	Total Loans Payments TotalLoansPayments	2717000	ils
CY2022Q4	asns	Exchange Rate ExchangeRate	1
CY2022Q4	asns	Exchange Rate ExchangeRate	3.519
	asns	Convertible Note Offering Amount ConvertibleNoteOfferingAmount	3000000	usd
	asns	Convertible Note Offering Percentage ConvertibleNoteOfferingPercentage	0.06	pure
CY2022Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.06	pure
CY2022Q1	asns	Convertible Note Offered ConvertibleNoteOffered	3000000	usd
CY2022Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	60000	usd
CY2022	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.40	pure
CY2022	asns	Convertible Note Description ConvertibleNoteDescription	The Notes had an optional conversion price at a 40% discount based on a $50m value in the event that an IPO is not consummated and if an IPO is not consummated within 18 months of the issuance of the Notes, the value of the Notes would be set at 110% of their then balance.
CY2022	asns	Addition Addition	1847000	usd
CY2022	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	1753000	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	3600000	usd
CY2022	us-gaap	Other Expenses OtherExpenses	1753000	usd
CY2017Q1	asns	Aggregrate Principal Amount AggregratePrincipalAmount	2000000	usd
CY2022Q2	asns	Ipo Scenario Estimated Percentage IPOScenarioEstimatedPercentage	0.75	pure
CY2021	asns	Ipo Scenario Estimated Percentage IPOScenarioEstimatedPercentage	0.375	pure
CY2017Q1	asns	Common Stock Reflecting Discount CommonStockReflectingDiscount	0.30	pure
CY2017Q1	asns	Additional Percentage AdditionalPercentage	0.01	pure
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4905000	usd
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3563000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1648000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1342000	usd
CY2022	asns	Conversion Of Stock Amount Issued ConversionOfStockAmountIssued	6553000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4905000	usd
CY2022	us-gaap	Credit Derivative Liquidation Proceeds Percentage CreditDerivativeLiquidationProceedsPercentage	1	pure
CY2022Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	14300000	usd
CY2022Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	15500000	usd
CY2022Q4	us-gaap	Recorded Unconditional Purchase Obligation Amount Of Maturities And Sinking Fund Requirements RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements	10000000	usd
CY2022	us-gaap	Payments For Loans PaymentsForLoans	221000	usd
CY2022Q4	us-gaap	Servicing Liability ServicingLiability	900000	usd
CY2021Q4	us-gaap	Servicing Liability ServicingLiability	818000	usd
CY2022	asns	Aggregate Gross Proceeds AggregateGrossProceeds	5000000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	15000000	usd
CY2022Q4	us-gaap	Share Price SharePrice	0.9991
CY2016Q3	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	73048	shares
CY2021	asns	Ipo Scenario Estimated Percentage IPOScenarioEstimatedPercentage	0.375	pure
CY2021	asns	Private Holding Percenatge PrivateHoldingPercenatge	0.625	pure
CY2021	asns	Volatility Percentage VolatilityPercentage	0.58	pure
CY2021	asns	Riskfree Rate Percentage RiskfreeRatePercentage	0.0097	pure
CY2021	us-gaap	Debt Instrument Term DebtInstrumentTerm	P0Y4M24D
CY2021	asns	Ipo Scenario Expected Term IPOScenarioExpectedTerm	P3Y
CY2022Q4	asns	Underlying Common Stock Price UnderlyingCommonStockPrice	0.477
CY2022	asns	Volatility Percentage VolatilityPercentage	0.57	pure
CY2022	asns	Risk Free Rate Percentage RiskFreeRatePercentage	0.0411	pure
CY2022	us-gaap	Debt Instrument Term DebtInstrumentTerm	P3Y7M6D
CY2021Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	2149000	usd
CY2020Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	1023000	usd
CY2022	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	1049000	usd
CY2021	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	1031000	usd
CY2021	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount	95000	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	3190000	usd
CY2022Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	8000	usd
CY2021Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	2149000	usd
CY2022	asns	Other Financial Expensesincome OtherFinancialExpensesincome	1049	usd
CY2021	asns	Other Financial Expensesincome OtherFinancialExpensesincome	1031000	usd
CY2022Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	30000000	shares
CY2022Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	17379861	shares
CY2022	asns	Nonvoting Common Stock Authorized NonvotingCommonStockAuthorized	2803774	shares
CY2021Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	11009315	shares
CY2021Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	2050404	shares
CY2021	asns	Nonvoting Common Stock Authorized NonvotingCommonStockAuthorized	2803774	shares
CY2021	asns	Nonvoting Common Stock Issued And Outstanding NonvotingCommonStockIssuedAndOutstanding	1783773	shares
CY2022Q2	asns	Total Authorized Shares TotalAuthorizedShares	42803774	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022	asns	Maximum Option Term MaximumOptionTerm	P10Y
CY2016Q1	us-gaap	Shares Held In Employee Stock Option Plan Committed To Be Released SharesHeldInEmployeeStockOptionPlanCommittedToBeReleased	216	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	890493	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.1518
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M4D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	167779	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.1964
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	77749	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.0812
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	15937	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.5089
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	964586	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.4891
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y4M2D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	771956	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.1476
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M9D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	879251	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0874
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	43261	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.3616
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	2763	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.1058
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	29256	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.0874
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	890493	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.1518
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y5M4D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	801562	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.276
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y1M6D
CY2022Q4	asns	Share Based Compensation Arrangement Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementWeightedAverageGrantDateFairValue	71	shares
CY2021Q4	asns	Share Based Compensation Arrangement Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementWeightedAverageGrantDateFairValue	54	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y4M24D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.54	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.58	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0097	pure
CY2022	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	3	usd
CY2021	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	3	usd
CY2022	asns	Research And Development ResearchAndDevelopment	26	usd
CY2021	asns	Research And Development ResearchAndDevelopment	24	usd
CY2022	asns	Sales And Marketing SalesAndMarketing	11	usd
CY2021	asns	Sales And Marketing SalesAndMarketing	16	usd
CY2022	asns	General And Administrative GeneralAndAdministrative	12	usd
CY2021	asns	General And Administrative GeneralAndAdministrative	10	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	52	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	53	usd
CY2022	asns	Share Based Compensation Arrangement By Share Based Payment Options Grants ShareBasedCompensationArrangementByShareBasedPaymentOptionsGrants	592000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.62
CY2022Q4	asns	Share Based Compensation Arrangement By Outstanding Numbers ShareBasedCompensationArrangementByOutstandingNumbers	592000	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.62
CY2021	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	0.1518	shares
CY2022Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	592000	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.62
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	21000	usd
CY2022	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	12000	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	135000	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	168000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.09	pure
CY2019Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3418	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Settlements Domestic IncomeTaxReconciliationTaxSettlementsDomestic	-4535000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Settlements Domestic IncomeTaxReconciliationTaxSettlementsDomestic	-3273000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Settlements Foreign IncomeTaxReconciliationTaxSettlementsForeign	-6447000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Settlements Foreign IncomeTaxReconciliationTaxSettlementsForeign	-1978000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Settlements IncomeTaxReconciliationTaxSettlements	-10982000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Settlements IncomeTaxReconciliationTaxSettlements	-5251000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27932000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	31049000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	27932000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	31049000	usd
CY2022	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	964586
CY2021	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	890493
CY2022	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	0.4891	shares
CY2021	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	7731083	shares
CY2022	asns	Redeemable Preferred Stock Outstanding RedeemablePreferredStockOutstanding	178281	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2022	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	8831000	usd
CY2021	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	8545000	usd
CY2022	asns	Schedule Of Revenues From Contract Liability ScheduleOfRevenuesFromContractLiability	<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Opening balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"> 673</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"> 581</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Revenue recognized that was included in the contract liability balance at the beginning of the period</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(593</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(452</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Additions</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">568</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">544</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Remaining performance obligations</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">648</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">673</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: left"> </p>
CY2022Q4	asns	Contract With Customer Liability Revenue Recognize ContractWithCustomerLiabilityRevenueRecognize	673000	usd
CY2021Q4	asns	Contract With Customer Liability Revenue Recognize ContractWithCustomerLiabilityRevenueRecognize	581000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-593000	usd
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-452000	usd
CY2022Q4	asns	Additions Additions	568000	usd
CY2021Q4	asns	Additions Additions	544000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	648000	usd
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	673000	usd
CY2022Q4	us-gaap	Purchase Obligation PurchaseObligation	648	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	80000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	726000	usd
CY2022	asns	Revenues Percentage RevenuesPercentage	0.10	pure
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	1648000	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	1342000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1753000	usd
CY2022	asns	Change In Warrants Fair Value ChangeInWarrantsFairValue	1049000	usd
CY2021	asns	Change In Warrants Fair Value ChangeInWarrantsFairValue	1031000	usd
CY2022	asns	Exchange Rates Differences ExchangeRatesDifferences	-506000	usd
CY2021	asns	Exchange Rates Differences ExchangeRatesDifferences	278000	usd
CY2022	us-gaap	Other Income OtherIncome	107000	usd
CY2021	us-gaap	Other Income OtherIncome	50000	usd
CY2022	us-gaap	Other General Expense OtherGeneralExpense	4051000	usd
CY2021	us-gaap	Other General Expense OtherGeneralExpense	2701000	usd
CY2015Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	106000	usd
CY2022Q2	us-gaap	Defined Benefit Plan Number Of Shares Of Equity Securities Issued By Employer And Related Parties Included In Plan Assets DefinedBenefitPlanNumberOfSharesOfEquitySecuritiesIssuedByEmployerAndRelatedPartiesIncludedInPlanAssets	27699	shares
CY2022Q2	asns	Related Party Transactions Purchases From Related Party RelatedPartyTransactionsPurchasesFromRelatedParty	4.55
CY2022Q2	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	126000	usd
CY2015Q1	asns	Related Party Fair Value Price Per Share RelatedPartyFairValuePricePerShare	0.55
CY2015Q1	us-gaap	Management Fee Expense ManagementFeeExpense	5000	usd
CY2022	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	150000	usd
CY2022	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	4000000	usd
CY2022Q1	us-gaap	Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount	100000	usd
CY2022Q2	us-gaap	Other Additional Capital OtherAdditionalCapital	50000	usd
CY2022Q1	asns	Aggregate Amount aggregateAmount	100000	usd
CY2022Q1	us-gaap	Collateralized Agreements CollateralizedAgreements	150000	usd
CY2017Q1	us-gaap	Convertible Debt ConvertibleDebt	26	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	592000	shares
CY2022Q4	asns	Directors Shares Transaction DirectorsSharesTransaction	100000	shares
CY2022Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1000000	usd
CY2022	asns	Total Share Price TotalSharePrice	50	usd
CY2021Q4	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent		usd
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent		usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability		usd
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent		usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount		usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount		usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q4	asns	Common Stock Value1 CommonStockValue1		usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
CY2021	asns	Changes In Fair Value Related To Convertible Note ChangesInFairValueRelatedToConvertibleNote		usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet		usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther		usd
CY2021	asns	Proceeds From Short Term Debts ProceedsFromShortTermDebts		usd
CY2021	asns	Proceeds From Issuance Long Term Debts ProceedsFromIssuanceLongTermDebts		usd
CY2021	asns	Restricted Long Term Bank Deposit RestrictedLongTermBankDeposit		usd
CY2021	asns	Restricted Bank Deposit RestrictedBankDeposit		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2021	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
CY2021	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
CY2022	asns	Additional Warrants AdditionalWarrants		usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2021	asns	Conversion Of Convertible Loan To Common Stock Upon Initial Public Offering ConversionOfConvertibleLoanToCommonStockUponInitialPublicOffering		usd
CY2021	asns	Conversion Of Convertible Note To Common Stock Upon Initial Public Offering ConversionOfConvertibleNoteToCommonStockUponInitialPublicOffering		usd
CY2021	asns	Conversion Of Warrants To Common Stock Upon Initial Public Offering ConversionOfWarrantsToCommonStockUponInitialPublicOffering		usd
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
CY2021	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense		usd
CY2021Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs		usd
CY2022Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs		usd
CY2022Q2	us-gaap	Long Term Debt Term LongTermDebtTerm	P3Y
CY2021	asns	Conversion Of Stock Amount Issued ConversionOfStockAmountIssued		usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue		usd
CY2022	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount		usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable		usd
CY2022	asns	Nonvoting Common Stock Issued And Outstanding NonvotingCommonStockIssuedAndOutstanding		shares
CY2021Q4	asns	Share Based Compensation Arrangement By Outstanding Numbers ShareBasedCompensationArrangementByOutstandingNumbers		shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022Q4	asns	Share Based Compensation Arrangements Weighted Average Exercise Price ShareBasedCompensationArrangementsWeightedAverageExercisePrice		shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
CY2022	asns	Share Based Compensation Arrangement By Forfeited ShareBasedCompensationArrangementByForfeited		shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2021	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense		usd
CY2021	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense		usd
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense		usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001141284

Files In Submission

Name	View Source	Status
asns-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001213900-23-024106-index-headers.html	Edgar Link	pending
0001213900-23-024106-index.html	Edgar Link	pending
0001213900-23-024106.txt	Edgar Link	pending
0001213900-23-024106-xbrl.zip	Edgar Link	pending
asns-20221231.xsd	Edgar Link	pending
ex10-12_001.jpg	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
f10k2022ex10-12_actelisnet.htm	Edgar Link	pending
f10k2022ex23-1_actelisnet.htm	Edgar Link	pending
f10k2022ex31-1_actelisnet.htm	Edgar Link	pending
f10k2022ex31-2_actelisnet.htm	Edgar Link	pending
f10k2022ex32-1_actelisnet.htm	Edgar Link	pending
f10k2022ex32-2_actelisnet.htm	Edgar Link	pending
f10k2022ex4-1_actelisnet.htm	Edgar Link	pending
f10k2022_actelisnet.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
asns-20221231_def.xml	Edgar Link	unprocessable
f10k2022_actelisnet_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
asns-20221231_cal.xml	Edgar Link	unprocessable
asns-20221231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ASNS
ACTELIS NETWORKS INC Stock $asns

2023 Q1 Form 10-K Financial Statement

#000121390023024106 Filed on March 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASNS ACTELIS NETWORKS INC Stock $asns

2023 Q1 Form 10-K Financial Statement

#000121390023024106 Filed on March 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASNS
ACTELIS NETWORKS INC Stock $asns